The NHS waiting list in England has reached 7.38 million, the third monthly rise in a row. Some measures of performance are improving, but record demand in A&E and the approach of winter raise questions about how quickly the NHS can deliver its recovery plans.
The number of people waiting for hospital treatment in England has risen for the third month running, undoing some of the progress made earlier this year.
Figures published by NHS England on 12 November show that 7.38 million treatment pathways were waiting to start consultant-led care at the end of September. That is about 10,000 more than in August, when the figure was 7.37 million. The list has grown by around 270,000 over the past six months, with rises in July, August and September.
The headline figure needs some context. A “pathway” is a course of treatment, not a person, and some patients are waiting for more than one. NHS England estimates that around 6.2 million individual patients are waiting. The total is also slightly lower than a year ago, so the longer-term picture is more complicated than the recent rises suggest.
From falling to rising
Earlier in 2026 there were signs of real progress. In February, Healthcare Management reported that the waiting list had fallen to 7.29 million in December 2025, its lowest level since February 2023. That came in a year when the NHS delivered a record 18.4 million treatments and operations, despite industrial action.
Keeping that momentum has proved difficult. The number of patients waiting more than 52 weeks has now risen for six months in a row, reaching 116,353.
There is some good news. The proportion of patients waiting no more than 18 weeks rose from 65.2% in August to 65.8% in September. That is the highest level since September 2021 and four percentage points better than a year earlier. So while the overall backlog is growing, more patients are being treated within the target time.
Is the government’s plan working?
The government has pledged that by March 2029, 92% of patients will start treatment within 18 weeks of referral, as the NHS Constitution requires. Its Elective Reform Plan, published in January 2025, aims to get there by increasing capacity, improving productivity and giving patients more choice over where and when they are treated.
An interim goal was for 65% of patients to be waiting no longer than 18 weeks by March 2026. That was met, with 65.3% at the end of March. September’s figure of 65.8% shows progress has continued, though only modestly since then.
The Royal College of Surgeons has warned that progress is stalling. It says sustained investment is needed in operating theatres, surgical beds and the workforce required to carry out more planned operations. It also points to the wider cost of long waits, including the effect on people’s ability to work and manage daily life.
The 2029 commitment remains in place, but the latest figures show the scale of the task.
Winter adds to the pressure
The NHS is also heading into winter with its emergency services under strain. October 2026 saw more than 2.5 million A&E attendances in England, the busiest October on record and 4.2% higher than a year earlier.
Overall, 74% of patients were admitted, transferred or discharged within four hours. At major, full-service emergency departments (known as Type 1), the figure was just 60.1%. During the month, 57,840 patients waited more than 12 hours from the decision to admit them to actually being admitted to a hospital bed.
Flu could add to the strain. The UK Health Security Agency recorded 855 new flu hospital admissions in the week to 45 of 2026, with the admission rate rising from 3.00 to 3.65 per 100,000 people. This remains in the “low impact” category, but health services will be watching closely.
The NHS has opened flu vaccine bookings earlier than in previous years and asked hospital trusts to stress-test their winter plans. Even so, rising A&E demand, respiratory illness and limited capacity mean the coming months will be tough.
What the numbers don’t show
The waiting-list total says little about individual experiences. September saw almost two million new pathways begin, while 323,789 were completed through hospital admission and a further 1.35 million through other routes, such as outpatient care. That is a great deal of activity, even with the backlog still high, and it is why the number of people being treated and the number still waiting should be read together.
For patients, the impact of waiting goes beyond the list itself. Delays can affect their ability to work, their daily activities and the management of long-term conditions. The goal is not only a smaller headline number, but timely, appropriate treatment for everyone who needs it.
Progress and pressure side by side
Three monthly rises and a growing number of year-long waits suggest that progress remains fragile. Yet the improving share of patients treated within 18 weeks shows that parts of elective care are moving in the right direction.
With A&E demand at record levels and flu activity starting to climb, this winter will test the NHS’s ability to balance urgent and planned care. Whether recent gains can be sustained and accelerated towards the 2029 target will be a key measure of the recovery plan. For now, the figures show progress and pressure existing side by side.
